Telepharmacy Safety: What Recent Research Reveals About Risks and Benefits
Mar 31 2026
Multiple System Atrophy (MSA-P) is a rare, aggressive neurological disorder with parkinsonian symptoms and severe autonomic failure. Unlike Parkinson’s, it progresses rapidly, responds poorly to treatment, and has a median survival of only 6-10 years.
Mar 31 2026
Dec 17 2025
Feb 11 2026
Feb 2 2026
Oct 4 2025